Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-05-011418
Filing Date
2005-04-26
Accepted
2005-04-26 16:12:28
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A a2156461z10-ka.txt 10-K/A 21629
2 EXHIBIT 10.64 a2156461zex-10_64.txt EX-10.64 4671
3 EXHIBIT 10.66 a2156461zex-10_66.txt EX-10.66 97315
4 EXHIBIT 10.67 a2156461zex-10_67.txt EX-10.67 196916
5 EXHIBIT 10.68 a2156461zex-10_68.txt EX-10.68 64426
6 EXHIBIT 31.1 a2156461zex-31_1.txt EX-31.1 4549
7 EXHIBIT 31.2 a2156461zex-31_2.txt EX-31.2 4534
8 EXHIBIT 32.1 a2156461zex-32_1.txt EX-32.1 1372
9 EXHIBIT 32.2 a2156461zex-32_2.txt EX-32.2 1370
  Complete submission text file 0001047469-05-011418.txt   398213
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30981 | Film No.: 05773288
SIC: 8731 Services-Commercial Physical & Biological Research